Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Davis Jerel. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Davis Jerel zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:TSBX / Turnstone Biologics Corp. | Director | 0 |
| US:KDNY / Chinook Therapeutics Inc | Director | 0 |
| US:RPTX / Repare Therapeutics Inc. | Director | 25 131 |
| US:GRPH / Graphite Bio, Inc. | Director, 10% Owner | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Davis Jerel. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Davis Jerel ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | -82 006 | 0 | -100,00 | ||||
| 2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | -90 888 | 0 | -100,00 | ||||
| 2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | -207 486 | 0 | -100,00 | ||||
| 2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | -2 726 322 | 0 | -100,00 | ||||
| 2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | -274 990 | 0 | -100,00 | ||||
| 2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | -210 996 | 0 | -100,00 | ||||
| 2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | -719 104 | 0 | -100,00 | ||||
| 2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | -2 105 107 | 0 | -100,00 | ||||
| 2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | -447 013 | 0 | -100,00 | ||||
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 5 939 | 82 006 | 7,81 | 12,00 | 71 268 | 984 072 | |
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 6 575 | 90 888 | 7,80 | 12,00 | 78 900 | 1 090 656 | |
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 15 028 | 207 486 | 7,81 | 12,00 | 180 336 | 2 489 832 | |
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 197 458 | 2 726 322 | 7,81 | 12,00 | 2 369 496 | 32 715 864 | |
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 274 990 | 274 990 | |||||
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 76 067 | 76 067 | |||||
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 84 313 | 84 313 | |||||
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 192 458 | 192 458 | |||||
| 2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 2 528 864 | 2 528 864 | |||||
| 2023-05-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 300 | 733 770 | 0,45 | ||||
| 2023-04-19 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -295 808 | 443 713 | -40,00 | 20,75 | -6 138 223 | 9 207 355 | |
| 2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -36 751 | 210 996 | -14,83 | 22,75 | -836 085 | 4 800 159 | |
| 2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -123 249 | 719 104 | -14,63 | 22,75 | -2 803 915 | 16 359 616 | |
| 2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -240 000 | 2 105 107 | -10,23 | 22,75 | -5 460 000 | 47 891 184 | |
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 014 | 25 131 | 13,63 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -4 721 | 0 | -100,00 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 721 | 4 721 | |||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -21 854 | 42 877 | -33,76 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 240 | 22 117 | 5,94 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -65 957 | 0 | -100,00 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 065 | 65 957 | 3,23 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -9 561 | 18 761 | -33,76 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 866 | 63 892 | 3,01 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -8 638 | 16 949 | -33,76 | ||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 62 026 | 62 026 | |||||
| 2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -287 157 | 563 403 | -33,76 | ||||
| 2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 646 | 739 521 | 0,22 | ||||
| 2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -9 465 | 0 | -100,00 | ||||
| 2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 5 865 | 9 465 | 162,92 | ||||
| 2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -108 715 | 247 747 | -30,50 | ||||
| 2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 3 600 | 3 600 | |||||
| 2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -364 587 | 842 353 | -30,21 | ||||
| 2022-12-13 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | -250 000 | 2 094 451 | -10,66 | 16,00 | -4 000 000 | 33 511 216 | |
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -9 384 | 0 | -100,00 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 9 384 | 9 384 | |||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 975 | 737 875 | 0,27 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -11 359 | 0 | -100,00 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 11 359 | 11 359 | |||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -567 963 | 2 345 107 | -19,50 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 316 | 735 900 | 0,18 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -7 570 | 0 | -100,00 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 4 692 | 7 570 | 163,03 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -86 972 | 356 462 | -19,61 | ||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 2 878 | 2 878 | |||||
| 2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -291 670 | 1 206 940 | -19,46 | ||||
| 2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 646 | 734 584 | 0,22 | ||||
| 2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -9 466 | 0 | -100,00 | ||||
| 2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 5 866 | 9 466 | 162,94 | ||||
| 2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -108 715 | 443 434 | -19,69 | ||||
| 2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 3 600 | 3 600 | |||||
| 2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -364 587 | 1 498 610 | -19,57 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 448 | 20 877 | 44,69 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -10 099 | 0 | -100,00 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 10 099 | 10 099 | |||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -46 753 | 64 731 | -41,94 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 653 | 14 429 | 22,53 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -141 103 | 0 | -100,00 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 419 | 141 103 | 3,23 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -20 454 | 28 322 | -41,93 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 992 | 136 684 | 3,01 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -18 478 | 25 587 | -41,93 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 132 692 | 132 692 | |||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -614 315 | 850 560 | -41,94 | ||||
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | -33 395 | 111 484 | -23,05 | 12,25 | -409 146 | 1 365 869 | |
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | -14 611 | 48 776 | -23,05 | 12,25 | -179 010 | 597 589 | |
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | -13 199 | 44 065 | -23,05 | 12,25 | -161 710 | 539 871 | |
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | -438 795 | 1 464 875 | -23,05 | 12,25 | -5 375 985 | 17 947 209 | |
| 2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | -250 000 | 2 344 451 | -9,64 | 12,25 | -3 062 925 | 28 723 510 | |
| 2022-05-16 |
|
4 | RPTX |
Repare Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
| 2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -11 726 | 0 | -100,00 | ||||
| 2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 11 726 | 11 726 | |||||
| 2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 2 468 | 732 938 | 0,34 | ||||
| 2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | -14 194 | 0 | -100,00 | ||||
| 2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 14 194 | 14 194 | |||||
| 2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | X | -709 953 | 2 913 070 | -19,60 | |||
| 2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -92 000 | 552 149 | -14,28 | 16,00 | -1 472 018 | 8 834 494 |
| 2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -308 000 | 1 863 197 | -14,19 | 16,00 | -4 928 062 | 29 811 525 |
| 2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | -600 000 | 3 623 023 | -14,21 | 16,00 | -9 600 120 | 57 969 093 |
| 2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -78 098 | 644 149 | -10,81 | 14,00 | -1 093 372 | 9 018 086 | |
| 2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -261 902 | 2 171 197 | -10,76 | 14,00 | -3 666 628 | 30 396 758 | |
| 2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | -510 000 | 4 223 023 | -10,78 | 14,00 | -7 140 000 | 59 122 322 | |
| 2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -2 260 | 0 | -100,00 | ||||
| 2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 260 | 2 260 | |||||
| 2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 19 | 11 776 | 0,16 | ||||
| 2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -2 279 | 0 | -100,00 | ||||
| 2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 279 | 2 279 | |||||
| 2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -152 071 | 231 211 | -39,68 | |||
| 2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Series B Preferred Stock |
C - Conversion | -3 715 415 | 0 | -100,00 | ||||
| 2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Series A Preferred Stock |
C - Conversion | -30 019 945 | 0 | -100,00 | ||||
| 2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
P - Purchase | 180 000 | 1 707 719 | 11,78 | 17,00 | 3 060 000 | 29 031 223 | |
| 2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
C - Conversion | 1 527 719 | 1 527 719 | |||||
| 2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
C - Conversion | 12 343 727 | 14 708 398 | 522,01 | ||||
| 2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
| 2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Series B Preferred Stock |
A - Award | 3 715 415 | 3 715 415 | 5,06 | 18 800 000 | 18 800 000 | ||
| 2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Series A Preferred Stock |
A - Award | 10 000 000 | 30 019 945 | 49,95 | 1,00 | 10 000 000 | 30 019 945 | |
| 2021-06-24 | 3 | GRPH |
Graphite Bio, Inc.
Common Stock |
2 364 671 | ||||||||
| 2021-06-07 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 5 948 | 5 948 | |||||
| 2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -1 119 | 0 | -100,00 | ||||
| 2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 119 | 1 119 | |||||
| 2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 9 | 11 757 | 0,08 | ||||
| 2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -1 128 | 0 | -100,00 | ||||
| 2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 128 | 1 128 | |||||
| 2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -75 000 | 383 282 | -16,37 | ||||
| 2021-05-14 |
|
4 | RPTX |
Repare Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 21 000 | 21 000 | |||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 912 | 11 748 | 8,42 | ||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -3 473 | 0 | -100,00 | ||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 473 | 3 473 | |||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -16 079 | 144 879 | -9,99 | |||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 930 | 10 836 | 21,67 | ||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -48 528 | 0 | -100,00 | ||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 520 | 48 528 | 3,23 | ||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -7 035 | 63 387 | -9,99 | |||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 373 | 47 008 | 3,01 | ||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -6 355 | 57 264 | -9,99 | |||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 45 635 | 45 635 | |||||
| 2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -211 277 | 1 903 670 | -9,99 | |||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -745 | 0 | -100,00 | ||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 8 906 | 0,07 | ||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -751 | 0 | -100,00 | ||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -50 000 | 458 282 | -9,84 | |||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -5 176 | 0 | -100,00 | ||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 176 | 5 176 | |||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 824 | 8 900 | 10,20 | ||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -6 000 | 0 | -100,00 | ||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 000 | 6 000 | |||||
| 2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -300 000 | 2 594 451 | -10,36 | |||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -745 | 0 | -100,00 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 8 076 | 0,07 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -751 | 0 | -100,00 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -50 000 | 508 282 | -8,96 | |||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -4 313 | 0 | -100,00 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 313 | 4 313 | |||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 687 | 8 070 | 9,31 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -5 000 | 0 | -100,00 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 000 | 5 000 | |||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -250 000 | 2 894 451 | -7,95 | |||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 764 | 7 383 | 59,84 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -4 328 | 0 | -100,00 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 328 | 4 328 | |||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -20 037 | 160 958 | -11,07 | |||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 820 | 4 619 | 65,02 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -60 472 | 0 | -100,00 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 893 | 60 472 | 3,23 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -8 766 | 70 422 | -11,07 | |||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 711 | 58 579 | 3,01 | ||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -7 919 | 63 619 | -11,07 | |||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 56 868 | 56 868 | |||||
| 2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -263 278 | 2 114 947 | -11,07 | |||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -745 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 2 799 | 0,21 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -751 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -50 000 | 558 282 | -8,22 | |||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -4 744 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 744 | 4 744 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 756 | 2 793 | 37,11 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -5 500 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 500 | 5 500 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -275 000 | 3 144 451 | -8,04 | |||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 975 | 2 037 | 91,81 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -1 388 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 388 | 1 388 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -11 688 | 180 995 | -6,07 | |||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 062 | 1 062 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | -35 276 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 105 | 35 276 | 3,23 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -5 113 | 79 188 | -6,07 | |||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 998 | 34 171 | 3,01 | ||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -4 620 | 71 538 | -6,07 | |||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 33 173 | 33 173 | |||||
| 2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -153 579 | 2 378 225 | -6,07 | |||
| 2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -21 707 | 192 683 | -10,13 | |||
| 2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -9 497 | 84 301 | -10,12 | |||
| 2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -8 579 | 76 158 | -10,12 | |||
| 2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | -285 217 | 2 531 804 | -10,12 | |||
| 2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Stock Option (right to buy) |
A - Award | 23 522 | 23 522 | |||||
| 2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 2 433 099 | 2 433 099 | |||||
| 2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 722 247 | 722 247 | |||||
| 2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 4 733 023 | 4 733 023 | |||||
| 2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 730 470 | 730 470 | |||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | -458 282 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | -875 568 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | -3 350 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | -3 708 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | -8 475 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | -111 361 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | -2 443 883 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | -61 791 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | -68 398 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | -156 335 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | -2 054 198 | 0 | -100,00 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
P - Purchase | 100 000 | 3 419 451 | 3,01 | 20,00 | 2 000 000 | 68 389 020 | |
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
P - Purchase | 150 000 | 608 282 | 32,73 | 20,00 | 3 000 000 | 12 165 640 | |
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 458 282 | 458 282 | |||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 875 568 | 3 319 451 | 35,83 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 3 350 | 84 737 | 4,12 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 3 708 | 93 798 | 4,12 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 8 475 | 214 390 | 4,12 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 111 361 | 2 817 021 | 4,12 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 2 443 883 | 2 443 883 | |||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 61 791 | 81 387 | 315,32 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 68 398 | 90 090 | 315,31 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 156 335 | 205 915 | 315,32 | ||||
| 2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 2 054 198 | 2 705 660 | 315,32 | ||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
| 2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 |